A b s t r a c t
Recent reports suggest that the finding of lobular neoplasia (atypical lobular hyperplasia [ALH] or lobular carcinoma in situ [LCIS]) in breast core needle biopsy specimens may be associated with an increased risk of both ductal carcinoma in situ (DCIS) or invasive
Such a finding seems unexpected, since lobular neoplasia traditionally has been associated with an increased risk of carcinoma for both breasts rather than an increased risk at that particular site. 1, 4 If this finding could be confirmed, patients with such a finding would seem to be candidates for routine excision rather than clinical follow-up. As a specific reaction to these reports, during the last year, we have been adding a note to reports for patients with lobular neoplasia revealed by breast core biopsy that recent studies suggest that patients with these findings may be at increased risk and excision may be warranted. However, our experience is that very few of these patients had either DCIS or invasive carcinoma identified in their subsequent excisions. To investigate this, we reviewed the results of all follow-up biopsies in patients with a diagnosis of lobular neoplasia alone or with coexisting atypical ductal hyperplasia (ADH) from a large series of breast core biopsies.
Materials and Methods
The results of breast core needle biopsy specimens interpreted from August 20, 1996, to August 31, 2001, at Baptist Hospital of Miami, Miami, FL, were reviewed. All biopsy specimens with a diagnosis of lobular neoplasia (either ALH or LCIS) alone or in conjunction with ADH were identified. Criteria for ADH were those identified by others. 5 In brief, these lesions were restricted to intraductal proliferations with some, but not sufficient, features of DCIS. The criteria for lobular neoplasia are those outlined by others. 1, 4 However, all cases that showed atypical features, such as LCIS with abnormally large cells, were classified for the purposes of this report as ADH and LCIS.
All breast core needle biopsy specimens were obtained by the clinicians; more than 95% were performed by the radiology department and consisted almost exclusively of specimens from 11-and 14-gauge core needle biopsies performed under ultrasound or stereotactic guidance.
All specimens were received fixed and routinely processed. Up to 5 cores were processed in a single block; if more than 5 cores were present, then an additional block was prepared. Each block was entirely sectioned to produce at least 5 slides and 2 levels per slide. 6 Statistical analysis was performed using a 2-tailed Fisher exact test.
Results
Patient and lesion characteristics for the entire group of biopsy specimens are detailed in ❚Table 1❚.
Results of excision for lobular neoplasia are detailed in ❚Table 2❚. We identified 71 cases of lobular neoplasia alone and 35 cases of lobular neoplasia associated with atypical ductal hyperplasia. The mean age of patients with lobular neoplasia and biopsy follow-up was 51.7 years and did not vary significantly between the 3 groups studied. Biopsy follow-up revealed DCIS or invasive carcinoma in none of 6 cases of ALH, none of 9 cases of LCIS, and DCIS in 1 of 11 cases with both ADH and LCIS. The incidence of DCIS in patients with ADH and lobular neoplasia (1/11 [9%]) was not different from that found in patients with ADH alone (13/95 [14%] cases P = 1.0 7 ).
Discussion
The goal of this study was simple: to determine whether the finding of lobular neoplasia in breast core needle biopsy specimens is associated with an increased risk of either DCIS or invasive carcinoma at excision. Such a finding would be both unexpected and important, since patients with such findings would need excision rather than clinical follow-up. Unlike previous reports, 2,3 we were unable to show any such increase in risk. There are several possible reasons for these divergent results. First, none of these series is very large; our report describes 15 patients with lobular neoplasia alone, and the previous reports describe 14 2 and 22 3 patients in which a total of 4 invasive carcinomas and 2 cases of DCIS, respectively, were identified. Thus, the rate of finding invasive carcinoma and DCIS is relatively low to begin with, and the precision of the rate is not great. It is entirely possible that it is not significantly greater than the rate found in patients with entirely benign findings such as fibrocystic changes, since no control group was reported in either previous report. In the present study there is no control group for patients with lobular neoplasia alone; however, since there were no cases with more significant lesions identified, it is not necessary. For patients with lobular neoplasia and ADH, a control group (patients with ADH alone) is presented, and the rate of significant findings is not different.
Second, it is possible that the patient populations studied were different. Although we attempted to thoroughly detail the characteristics of the patients in this report, the information concerning previous reports is limited since they are, to our knowledge, available only in abstract form. Similarly, the extent of histologic processing and sampling 6 in previous reports is not known. Third, the criteria for lobular neoplasia in the different studies may be different. While the criteria for lobular neoplasia are relatively straightforward and most likely more reproducible than those for ADH, 5, 7 it is possible that we have a lower threshold for the diagnosis than the pathologists in other reports, and this would account for our lower rate of significant findings at excision. However, the overall rate of lobular neoplasia alone in this study was only 1.65% (Table  1) , which is not very high. In addition, if we were overdiagnosing lobular neoplasia, then one would expect to see a difference between patients with ALH and LCIS. Specifically, one would expect to see a lower rate of significant findings in patients with ALH than in patients with LCIS, but this was not the case. On the other hand, it is possible that the pathologists in other studies may have had too high a threshold for identifying cases of LCIS that had atypical features. We specifically classified any case with atypical features as ADH and LCIS. Recent studies suggest that some cases that resemble LCIS on routine stains may, in fact, be better classified as an atypical ductal proliferation. 8 If these cases were classified simply as lobular neoplasia, one would not be surprised to see an increased rate of DCIS and invasive carcinoma at excision. At the very least, the implication of these reports together is that cases of atypical lobular neoplasia should be distinguished from those with more typical features.
Finally, in our opinion, the most likely source of the difference in the results between the present study and previous reports relates to sampling. In our opinion, sampling is the most likely source of differences in the rate of DCIS at excision after a diagnosis of ADH in a core needle biopsy specimen. 7 Simply put, our radiologists remove a lot of tissue, and it is rare for significant lesions to be left behind. Unfortunately there is no way to directly compare the amount of tissue removed in biopsy specimens between this and other studies. However, as mentioned before, it would be very important for studies that report an increased incidence of significant findings after a diagnosis of lobular neoplasia in breast core biopsy specimens to show that this rate is significantly different from that seen in patients with entirely benign biopsy specimens.
Our results suggest that lobular neoplasia in breast core biopsy specimens is not associated with an increased risk of either DCIS or invasive carcinoma at excision, and patients with this finding and no other clinical or pathologic indications for biopsy can be followed up rather than routinely undergo excision.
